Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the devastating global COVID-19 pandemic announced by WHO in March 2020. Through …

Background At the end of December 2019, a novel strain of Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) disease (COVID-19) has been identified in Wuhan …

Abstract Announced on December 31, 2019, the novel coronavirus arising in Wuhan City,
Hubei Province resulted in millions of cases and lives lost. Following intense tracking …

ABSTRACT SARS-CoV-2 variants with undetermined properties have emerged
intermittently throughout the COVID-19 pandemic. Some variants possess unique …

Genomic surveillance represents a strategy to understanding the evolutionary mechanisms,
transmission, and infectivity of different SARS-CoV-2 variants. We evaluated 603 individuals …

Viral tropism is most commonly linked to receptor use, but host cell protease use can be a
notable factor in susceptibility to infection. Here we review the use of host cell proteases by …

SARS-CoV-2 has the ability to form large multi-nucleated cells known as syncytia. Little is
known about how syncytia affect the dynamics of the infection or severity of the disease. In …

The massive surge of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
had significant implications for the population of the entire world during the ongoing …

Les mécanismes pathogéniques impliqués dans les phases initiales de l'infection par le
SARS-CoV-2 restent mal compris au niveau pulmonaire, en dépit d'une abondante activité …

Two of the most severe pandemics in recent history have been caused by respiratory
pathogens-Influenza A virus (IAV) and SARS-CoV-2 virus (SCV2). Although both pathogens …